MOLECULAR GENETICS AND METABOLISM

Scope & Guideline

Unraveling the Complexities of Molecular Interactions

Introduction

Explore the comprehensive scope of MOLECULAR GENETICS AND METABOLISM through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore MOLECULAR GENETICS AND METABOLISM in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1096-7192
PublisherACADEMIC PRESS INC ELSEVIER SCIENCE
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1998 to 2024
AbbreviationMOL GENET METAB / Mol. Genet. Metab.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address525 B ST, STE 1900, SAN DIEGO, CA 92101-4495

Aims and Scopes

The journal "Molecular Genetics and Metabolism" primarily focuses on advancing the understanding of genetic and metabolic disorders through innovative research methodologies. It serves as a platform for disseminating findings related to the molecular and biochemical bases of inherited metabolic diseases, genetic variations, and treatment approaches.
  1. Genetic and Molecular Basis of Inherited Disorders:
    Research exploring the genetic mutations and molecular mechanisms underlying various inherited metabolic disorders, providing insights into their pathophysiology.
  2. Clinical Applications and Treatment Strategies:
    Studies that evaluate the efficacy of current treatments, including enzyme replacement therapies and novel pharmacological approaches, aimed at improving patient outcomes.
  3. Biochemical and Metabolic Profiling:
    Investigations into the metabolic profiles associated with specific genetic disorders to identify biomarkers for diagnosis and treatment monitoring.
  4. Patient-Centric Research:
    Research that emphasizes patient experiences, quality of life, and caregiver perspectives, contributing to a holistic understanding of the impact of metabolic diseases.
  5. Innovative Therapeutic Approaches:
    Development and evaluation of innovative therapies, including gene therapy, substrate reduction therapy, and pharmacological chaperones, to address metabolic disorders.
Recent publications indicate a trend towards more innovative and patient-focused research themes within the field of molecular genetics and metabolism. These emerging areas are vital for advancing understanding and treatment of genetic disorders.
  1. Gene Therapy and Genome Editing:
    An increasing number of studies focus on gene therapy techniques, including CRISPR and AAV-mediated gene delivery, highlighting their potential in treating metabolic disorders.
  2. Patient-Reported Outcomes and Quality of Life:
    Research emphasizing the importance of patient-reported outcomes and the psychosocial impact of metabolic diseases is gaining prominence, reflecting a shift towards patient-centered care.
  3. Multi-Omics Approaches:
    There is a growing trend towards integrating genomics, proteomics, and metabolomics to provide a more comprehensive understanding of metabolic disorders and their treatment.
  4. Telemedicine and Remote Monitoring:
    The COVID-19 pandemic has accelerated research into telemedicine and remote monitoring strategies, showcasing their effectiveness in managing patient care during public health crises.
  5. Personalized Medicine:
    Emerging themes in personalized medicine highlight the need for tailored treatment approaches based on individual genetic profiles, enhancing therapeutic efficacy.

Declining or Waning

While the journal remains focused on genetic and metabolic research, certain themes have shown a decline in prominence over recent years, reflecting shifts in research priorities and advancements in technology.
  1. Traditional Diagnostic Methods:
    There has been a noticeable decrease in publications focused on conventional diagnostic methods, as newer genomic and metabolomic techniques gain traction.
  2. General Population Studies:
    Research involving broad population studies without a specific focus on genetic or metabolic disorders has diminished, as more targeted studies are preferred.
  3. Basic Biochemistry without Clinical Relevance:
    Papers that explore basic biochemical pathways without direct clinical applications or implications for patient care are becoming less frequent.
  4. Animal Models with Limited Translational Relevance:
    Research utilizing animal models that do not effectively translate to human conditions or lack clear therapeutic implications is less commonly published.

Similar Journals

Hormones-International Journal of Endocrinology and Metabolism

Pioneering Insights into Diabetes and Metabolic Disorders
Publisher: SPRINGER INT PUBL AGISSN: 1109-3099Frequency: 4 issues/year

Hormones - International Journal of Endocrinology and Metabolism, published by Springer International Publishing AG, is a vital resource within the field of Endocrinology, Diabetes, and Metabolism. Since its inception in 2005, this journal has made significant contributions to the understanding of hormonal mechanisms and their implications across various medical disciplines. With a current impact factor that places it in the Q3 category for Endocrinology and the Q2 category for miscellaneous Medicine – as indicated by its Scopus rankings – it stands out as a reputable platform for cutting-edge research and clinical findings. Although it operates under a subscription model, the journal's comprehensive scope encompasses basic and applied scientific studies, making it essential reading for researchers, clinicians, and students alike. The journal is headquartered in Germany with a strong commitment to promoting scholarly communication and knowledge dissemination within its specialized fields through the year 2024 and beyond.

GENETICS AND MOLECULAR BIOLOGY

Fostering collaboration in the realm of genetics.
Publisher: SOC BRASIL GENETICAISSN: 1415-4757Frequency: 4 issues/year

GENETICS AND MOLECULAR BIOLOGY, published by the SOC BRASIL GENETICA, is a prominent journal dedicated to the advancement of knowledge in the fields of genetics and molecular biology. Since its inception in 1998, this Open Access journal has served as a vital platform for researchers, professionals, and students to disseminate their findings and engage with the latest innovations and discoveries. With an impact factor that reflects its growing influence, GENETICS AND MOLECULAR BIOLOGY ranks in the Q3 category for both genetics and molecular biology as of 2023, indicating its position within the academic community. The journal is indexed in Scopus, highlighting its commitment to maintaining rigorous peer-review standards while providing wide-reaching access to quality research. Operating out of Ribeirão Preto, Brazil, it fosters a collaborative environment for academic discourse and research development not only in Brazil but also globally. The journal encourages submissions that explore a wide range of topics in genetics and molecular biology, making it an essential resource for anyone involved in these dynamic fields.

Molecular Genetics and Metabolism Reports

Unveiling the Genetic Blueprint of Human Health
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Molecular Genetics and Metabolism Reports is a peer-reviewed, open-access journal published by Elsevier that has been serving the scientific community since its inception in 2014. With an E-ISSN of 2214-4269, this journal focuses on publishing high-quality research in the rapidly evolving fields of *molecular genetics*, *endocrinology*, and *molecular biology*. Despite its relatively short history, the journal has established itself within the academic landscape, evidenced by its categorization in the 2023 Q3 quartile rankings for its respective fields, including genetics and molecular biology. Researchers and students are encouraged to disseminate their findings, as the open-access model provides unrestricted access to vital research, facilitating knowledge sharing and collaboration across disciplines. The journal aims to promote innovative studies that explore the genetic and metabolic underpinnings of human health, making it an essential resource for professionals seeking to stay abreast of the latest advancements and trends in molecular genetics and metabolism.

ACTA BIOCHIMICA POLONICA

Pioneering Research for Tomorrow's Scientific Breakthroughs
Publisher: ACTA BIOCHIMICA POLONICAISSN: 0001-527XFrequency: 4 issues/year

ACTA BIOCHIMICA POLONICA (ISSN: 0001-527X, E-ISSN: 1734-154X) is a distinguished journal published by the ACTA BIOCHIMICA POLONICA in Poland, with a rich history dating back to 1955. As a prominent platform for disseminating research, it currently holds a Category Quartile of Q3 in the fields of Biochemistry, Genetics, and Molecular Biology, reflecting its commitment to advancing knowledge in these critical areas. This journal is indexed in Scopus, ranking 124 out of 221, placing it in the 44th percentile among general biochemistry, genetics, and molecular biology journals. Although it does not operate under an open-access model, ACTA BIOCHIMICA POLONICA remains a vital resource for researchers, professionals, and students seeking to delve into the latest developments and discoveries in biochemistry and molecular biology. Its strategic focus on contemporary topics ensures that it plays an essential role in shaping future scientific inquiries and fostering collaboration across various disciplines.

Cell Communication and Signaling

Exploring the Nuances of Molecular Signaling
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.

INTERNATIONAL JOURNAL OF HUMAN GENETICS

Advancing the Frontiers of Human Genetics
Publisher: KAMLA-RAJ ENTERPRISESISSN: 0972-3757Frequency: 4 issues/year

INTERNATIONAL JOURNAL OF HUMAN GENETICS is a distinguished publication dedicated to advancing knowledge in the fields of genetics and molecular biology. Published by KAMLA-RAJ ENTERPRISES, this journal explores critical developments and research findings from 2008 to 2016, though its coverage in Scopus has since been discontinued. With an ISSN of 0972-3757 and an E-ISSN of 2456-6330, the journal aimed to foster scholarly dialogue and serve as a resource for researchers, professionals, and students engaged in human genetics. While the journal holds a modest ranking in categories such as Biochemistry and Genetics, it remains a vital source for exploring niche topics within the realm of human genetics. Researchers interested in genetic screening, gene therapy, and clinical genetics will find valuable insights herein. Despite its pause in indexing, the journal continues to contribute to the academic discourse by disseminating critical research that bridges gaps in understanding human genetics.

ENDOCRINE RESEARCH

Illuminating the complexities of endocrinology.
Publisher: TAYLOR & FRANCIS INCISSN: 0743-5800Frequency: 4 issues/year

ENDOCRINE RESEARCH is a prominent peer-reviewed journal published by TAYLOR & FRANCIS INC, focused on the dynamic field of endocrinology. With an ISSN of 0743-5800 and an E-ISSN of 1532-4206, this journal has been contributing to the scientific community since 1974, providing a platform for researchers to disseminate innovative findings related to hormonal research and its implications in diverse medical contexts. Operating from the United States, it falls within the Q3 quartile ranking in both Endocrinology and Medicine (Miscellaneous), reflecting its recognized impact within these disciplines. While ENDOCRINE RESEARCH currently does not offer open access options, it remains an invaluable resource for professionals, students, and researchers seeking to stay at the forefront of endocrine science and clinical application. The journal invites original research articles, reviews, and case studies, fostering a collaborative environment for discussing the complexities of endocrinological phenomena.

Genetics Research

Exploring the Frontiers of Genetic Discovery
Publisher: HINDAWI LTDISSN: 0016-6723Frequency: 1 issue/year

Genetics Research, published by HINDAWI LTD, is a distinguished open access journal that has been at the forefront of genetic studies since its inception in 1960. With the transition to open access in 2019, this journal has expanded its accessibility, fostering knowledge dissemination across the global scientific community. Operating out of the United Kingdom, it provides a platform for innovative research in the fields of genetics and molecular biology, encompassing a broad range of topics that are highly relevant to medical sciences. As of 2023, it holds a Q4 classification in Genetics and a Q3 classification in miscellaneous Medicine, reflecting its ongoing commitment to scholarly excellence amidst shifting academic landscapes. While the journal's H-index remains unlisted, its indexed ranking within Scopus, with a rank of #325/328 in the Genetics category highlights the challenges ligated to its niche audience. Nevertheless, it serves as a crucial resource for researchers, professionals, and students eager to contribute to and stay informed on the latest genetic research trends and breakthroughs.

Archives of Endocrinology Metabolism

Unveiling the latest breakthroughs in hormonal research.
Publisher: SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIAISSN: 2359-3997Frequency: 6 issues/year

Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.

Bone Reports

Pioneering discoveries in bone and metabolic health.
Publisher: ELSEVIERISSN: 2352-1872Frequency: 2 issues/year

Bone Reports is a premier, peer-reviewed journal published by Elsevier that has been committed to advancing the field of orthopedics, sports medicine, and endocrinology since its inception as an open-access journal in 2015. With an ISSN of 2352-1872, this esteemed publication seeks to disseminate high-quality research that spans a diverse array of topics related to bone health, metabolic diseases, and musculoskeletal disorders. The journal boasts an impressive impact factor, contributing significantly to its recognition, with a Q2 ranking in Orthopedics and Sports Medicine and a Q3 ranking in Endocrinology, Diabetes, and Metabolism as of 2023. This open-access model enhances accessibility and engagement, allowing researchers, professionals, and students alike to stay at the forefront of developments in these critical areas. With an emphasis on rigorous methodology and innovative findings, Bone Reports is poised to become a vital resource for anyone interested in the latest advances in bone research and clinical applications.